NCT00516373
- Conditions
- Adnexal Diseases, BRCA1 Protein, BRCA2 Protein, +15 more
- Locations
-
- Research Site Brussels, Belgium
- Research Site Amsterdam, Netherlands
- Research Site Szczecin, Poland
- Research Site Edinburgh, United Kingdom
Clinical trial condition
Explore clinical trials studying BRCA1 Protein. Study availability and eligibility vary by location and protocol.
NCT00516373